FDA Approved: ZYMFENTRA — Original Application (CELLTRION USA Inc.)

View source ↗

Summary

FDA approved ZYMFENTRA (inflximab-dyyb) from Celltrion USA as a biosimilar to infliximab (Remicade), based on demonstration of biosimilarity in analytical, nonc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Crohn Disease
• Plaque Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis
• Ulcerative Colitis

Drugs mentioned

• Zymfentra (Infliximab-dyyb)

Snippet

ORIG AP for ZYMFENTRA (INFLIXIMAB-DYYB)